RIGL Historical PE Ratio image   This RIGL PE ratio history page last updated 8/4/2022
RIGL Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/2/2022
1.30-0.08-0.32NA
Q1 2022
5/3/2022
2.48-0.16-0.64NA
Q4 2021
3/1/2022
2.51-0.11-0.44NA
Q3 2021
11/2/2021
3.57-0.12-0.48NA
Q2 2021
8/3/2021
3.78-0.08-0.32NA
Q1 2021
5/5/2021
3.470.220.883.9
Q4 2020
3/2/2021
4.31-0.11-0.44NA
Q3 2020
11/5/2020
2.74-0.08-0.32NA
Q2 2020
8/4/2020
2.46-0.10-0.40NA
Q1 2020
5/5/2020
1.960.130.523.8
Q4 2019
2/27/2020
2.04-0.10-0.40NA
Q3 2019
11/5/2019
2.17-0.07-0.28NA
Q2 2019
8/6/2019
2.17-0.12-0.48NA
Q1 2019
5/7/2019
2.32-0.11-0.44NA
Q4 2018
2/28/2019
2.190.020.0827.4
Q3 2018
11/6/2018
2.89-0.14-0.56NA
Q2 2018
8/8/2018
2.68-0.16-0.64NA
Q1 2018
5/1/2018
3.70-0.17-0.68NA
Q4 2017
3/6/2018
3.87-0.18-0.72NA
Q3 2017
11/7/2017
3.84-0.14-0.56NA
Q2 2017
8/1/2017
2.33-0.16-0.64NA
Q1 2017
5/2/2017
2.84-0.13-0.52NA
Q4 2016
3/7/2017
2.61-0.16-0.64NA
Q3 2016
11/1/2016
2.58-0.24-0.96NA
Q2 2016
8/2/2016
2.52-0.15-0.60NA
Q1 2016
5/3/2016
2.74-0.19-0.76NA
Q4 2015
3/8/2016
2.27-0.14-0.56NA
Q3 2015
11/3/2015
2.95-0.08-0.32NA
Q2 2015
8/4/2015
3.16-0.16-0.64NA
Q1 2015
5/7/2015
4.03-0.21-0.84NA
Q4 2014
3/3/2015
2.82-0.25-1.00NA
Q3 2014
11/4/2014
1.93-0.24-0.96NA
Q2 2014
8/5/2014
3.18-0.29-1.16NA
Q1 2014
5/7/2014
2.75-0.25-1.00NA
Q4 2013
3/4/2014
3.70-0.19-0.76NA
Q3 2013
11/5/2013
2.88-0.27-1.08NA
Q2 2013
8/6/2013
4.14-0.26-1.04NA
Q1 2013
5/7/2013
4.53-0.29-1.16NA
Q4 2012
3/4/2013
6.82-0.30-1.20NA
Q3 2012
11/6/2012
8.76-0.36-1.44NA
Q2 2012
8/7/2012
10.31-0.35-1.40NA
Q1 2012
5/8/2012
8.49-0.32-1.28NA
RIGL PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/2/2022
1.30-0.08-0.47NA
Q1 2022
5/3/2022
2.48-0.16-0.47NA
Q4 2021
3/1/2022
2.51-0.11-0.09NA
Q3 2021
11/2/2021
3.57-0.12-0.09NA
Q2 2021
8/3/2021
3.78-0.08-0.05NA
Q1 2021
5/5/2021
3.470.22-0.07NA
Q4 2020
3/2/2021
4.31-0.11-0.16NA
Q3 2020
11/5/2020
2.74-0.08-0.15NA
Q2 2020
8/4/2020
2.46-0.10-0.14NA
Q1 2020
5/5/2020
1.960.13-0.16NA
Q4 2019
2/27/2020
2.04-0.10-0.40NA
Q3 2019
11/5/2019
2.17-0.07-0.28NA
Q2 2019
8/6/2019
2.17-0.12-0.35NA
Q1 2019
5/7/2019
2.32-0.11-0.39NA
Q4 2018
2/28/2019
2.190.02-0.45NA
Q3 2018
11/6/2018
2.89-0.14-0.65NA
Q2 2018
8/8/2018
2.68-0.16-0.65NA
Q1 2018
5/1/2018
3.70-0.17-0.65NA
Q4 2017
3/6/2018
3.87-0.18-0.61NA
Q3 2017
11/7/2017
3.84-0.14-0.59NA
Q2 2017
8/1/2017
2.33-0.16-0.69NA
Q1 2017
5/2/2017
2.84-0.13-0.68NA
Q4 2016
3/7/2017
2.61-0.16-0.74NA
Q3 2016
11/1/2016
2.58-0.24-0.72NA
Q2 2016
8/2/2016
2.52-0.15-0.56NA
Q1 2016
5/3/2016
2.74-0.19-0.57NA
Q4 2015
3/8/2016
2.27-0.14-0.59NA
Q3 2015
11/3/2015
2.95-0.08-0.70NA
Q2 2015
8/4/2015
3.16-0.16-0.86NA
Q1 2015
5/7/2015
4.03-0.21-0.99NA
Q4 2014
3/3/2015
2.82-0.25-1.03NA
Q3 2014
11/4/2014
1.93-0.24-0.97NA
Q2 2014
8/5/2014
3.18-0.29-1.00NA
Q1 2014
5/7/2014
2.75-0.25-0.97NA
Q4 2013
3/4/2014
3.70-0.19-1.01NA
Q3 2013
11/5/2013
2.88-0.27-1.12NA
Q2 2013
8/6/2013
4.14-0.26-1.21NA
Q1 2013
5/7/2013
4.53-0.29-1.30NA
Q4 2012
3/4/2013
6.82-0.30-1.33NA
Q3 2012
11/6/2012
8.76-0.36NANA
Q2 2012
8/7/2012
10.31-0.35NANA
Q1 2012
5/8/2012
8.49-0.32NANA
Quotes delayed 20 minutes

Email EnvelopeFree RIGL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Rigel Pharmaceuticals (RIGL) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

RLAY PE Ratio History
RLMD PE Ratio History
RLYB PE Ratio History
RMD PE Ratio History
RMED PE Ratio History
RMTI PE Ratio History
RNA PE Ratio History
RNAZ PE Ratio History
RNXT PE Ratio History
RPHM PE Ratio History
How should the RIGL historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Rigel Pharmaceuticals. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this RIGL Historical PE Ratio page.

What is the average historical PE for RIGL based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The RIGL historical PE ratio using the annualized quarterly earnings method works out to 11.7.

What is the average historical PE for RIGL based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The RIGL historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the RIGL Historical PE Ratio information for Rigel Pharmaceuticals' stock. The average RIGL historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 11.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average RIGL historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this RIGL historical PE result, against the recent PE: when this page was posted on 8/3/2022, the most recent closing price for RIGL had been 1.41, and the most recent quarterly earnings result, annualized, was 0.88. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent RIGL PE on 8/3/2022 based on annualized quarterly EPS was 1.6. Based on RIGL's history, that recent PE is low relative to the historical average, with the recent PE 86.3% lower than the historical average PE across our data set for Rigel Pharmaceuticals.

For self directed investors doing their due diligence on RIGL or any other given stock, valuation analysis for RIGL can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Rigel Pharmaceuticals PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RIGL. Thanks for visiting, and the next time you need to research RIGL Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Institutional Holders of XPOA, Funds Holding TWTC, PRSP Insider Buying.

 

RIGL Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.